How epidemiology has contributed to a better understanding of skin disease

Journal of Investigative Dermatology

Volumn 132, Issue 3 PART 2, 2012, Pages 994-1002

  Nijsten, Tamar ^a   Stern, Robert S ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CARBAMAZEPINE; CEFTRIAXONE; CYCLOSPORIN; DOXYCYCLINE; HLA B15 ANTIGEN; ISOTRETINOIN; PSORALEN;

ACNE; BORRELIA BURGDORFERI; CANCER REGISTRY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARDITIS; CASE CONTROL STUDY; CASE STUDY; CHECKLIST; COHORT ANALYSIS; COMORBIDITY; DRUG HYPERSENSITIVITY; ENCEPHALITIS; EPIDEMIOLOGICAL DATA; FOLLOW UP; HAPLOTYPE; HIGH RISK POPULATION; HUMAN; INFLAMMATION; LYME DISEASE; MELANOMA; META ANALYSIS (TOPIC); NONHUMAN; OBSERVATIONAL STUDY; PATIENT CARE; PRIORITY JOURNAL; PSORIASIS; PUVA; RADIATION CARCINOGENESIS; RADIATION EXPOSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SKIN DISEASE; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; STEVENS JOHNSON SYNDROME; STRENGTHENING THE REPORTING OF OBSERVATIONAL STUDIES IN EPIDEMIOLOGY CHECKLIST; SYSTEMATIC REVIEW (TOPIC); TERATOGENICITY; TOXIC EPIDERMAL NECROLYSIS;

EID: 84856901016     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.372     Document Type: Review

References (48)

1. Altman DG, Bland JM (1995) Absence of evidence is not evidence of absence. BMJ 311:485
2. Bastuji-Garin S, Rzany B, Stern RS et al. (1993) Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129:92-6 (Pubitemid 23029676)
3. Bhate C, Schwartz RA (2011) Lyme disease: Part I. Advances and perspectives. J Am Acad Dermatol 64:619-36
4. Burgdorfer W, Barbour AG, Hayes SF et al. (1982) Lyme disease-a tick-borne spirochetosis? Science 216:1317-9
5. Chapman PB, Hauschild A, Robert C et al. (2011) Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 364:2507-16
6. Chung W, Hung S, Hong H et al. (2004) A marker for Stevens-Johnson syndrome. Nature 428:486 (Pubitemid 38480527)
7. Dai WS, LaBraico JM, Stern RS (1992) Epidemiology of isotretinoin exposure during pregnancy. J Am Acad Dermatol 26:599-606
8. Flaherty KT, Puzanov I, Kim KB et al. (2010) Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med 363:809-19
9. Gardner MJ, Altman DG (1986) Confidence intervals rather than P values: Estimation rather than hypothesis testing. BMJ 292:746-50 (Pubitemid 16167414)
10. Gelfand JM, Neimann AL, Shin DB et al. (2006) Risk of myocardial infarction in patients with psoriasis. JAMA 296:1735-41 (Pubitemid 44547793)
11. Glasziou P, Vandenbroucke JP, Chalmers I (2004) Assessing the quality of research. BMJ 328:39-41 (Pubitemid 38067746)
12. Greenland S, Lash TL (2008) Bias analysis. In: Modern Epidemiology (Rothman KJ, Greenland S, Lash TL eds), 3rd edn, Philadelphia: Lippincott-Raven 345-80
13. Hill AB (1965) The environment and disease: Association or causation? J R Soc Med 58:295-300
14. Karim-Kos HE, de Vries E, Soerjomataram I et al. (2008) Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 44:1345-89
15. Katz MH (2003) Multivariable analysis: A primer for readers of medical research. Ann Intern Med 38:644-50 (Pubitemid 38124656)
16. Langan S, Schmitt J, Coenraads P-J, et al., on behalf of the European Dermato-Epidemiology Network (EDEN (2010) The reporting of observational research studies in dermatology journals: A literature-based study. Arch Dermatol 146:534-41
17. Lim JL, Stern RS (2005) High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients. J Invest Dermatol 124:505-13 (Pubitemid 40381572)
18. Maldonado JL, Fridlyand J, Patel H et al. (2003) Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 95:1878-90
19. Manriquez JJ, Villouta MF, Williams HC (2007) Evidence-based dermatology: Number needed to treat and its relation to other risk measures. J Am Acad Dermatol 56:664-71 (Pubitemid 46402953)
20. Marcil I, Stern RS (2001) Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: Nested cohort crossover study. Lancet 358:1042-5 (Pubitemid 32925124)
21. Mockenhaupt M, Viboud C, Dunant A et al. (2008) Stevens-Johnson syndrome and toxic epidermal necrolysis: Assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol 128:35-44 (Pubitemid 350249390)
22. Mueller W, Herrmann B (1979) Cyclosporin A for psoriasis. N Engl J Med 301:555 (Pubitemid 9258270)
23. Naldi L, Chatenoud L, Linder D et al. (2005) Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: Results from an Italian case-control study. J Invest Dermatol 125:61-7 (Pubitemid 40981424)
24. Ness RB, Andrews EB, Gaudino JA Jr. et al. (2009) The future of epidemiology. Acad Med 84:1631-7
25. Nijsten T, Spuls P, Stern RS (2008) STROBE: A Beacon for observational studies. Arch Dermatol 144:1200-4
26. Nijsten T, Wakkee M (2009) Complexity of the association between psoriasis and comorbidities. J Invest Dermatol 129:1601-3
27. Nijsten TE, Stern RS (2003a) The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: A cohort study. J Invest Dermatol 121:252-8 (Pubitemid 36969897)
28. Nijsten TE, Stern RS (2003b) Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-UVA: A nested cohort study. J Am Acad Dermatol 49:644-50 (Pubitemid 37210277)
29. Parrish JA, Fitzpatrick TB, Tanenbaum L et al. (1974) Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med 291:1207-11
30. Poikolainen K, Karvonen J, Pukkala E (1999) Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis. Arch Dermatol 135:1490-3
31. Rothman KJ, Greenland S, Poole C et al. (2008) Causation and causal inference. In: Modern Epidemiology (Rothman KJ, Greenland S, Lash TL eds), 3rd edn, Philadelphia: Lippincott-Raven 5-31
32. Rosa FW (1983) Teratogenicity of isotretinioin. Lancet 2:513
33. Roujeau J, Kelly JP, Naldi L et al. (1995) Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 333:1600-7
34. Sackett DL (1979) Bias in analytic research. J Chronic Dis 32:51-63
35. Schrock CG (1982) Lyme disease: Additional evidence of widespread distribution: Recognition of a tick-borne dermatitis-encephalitis-arthritis syndrome in an areas of known ixodes tick distribution. Am J Med 72:700-2 (Pubitemid 12089347)
36. Setty AR, Curhan G, Choi HK (2007) Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. Arch Intern Med 167:1670-5 (Pubitemid 47280349)
37. Steere AC, Malawista SE, Snydman DR et al. (1977) Lyme arthritis: An epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 20:7-17
38. Stern RS (1989) When a uniquely effective drug is teratogenic. The case of isotretinoin. N Engl J Med 320:1007-9 (Pubitemid 19101620)
39. Stern RS (1992) The prevalence of acne on the basis of physical examination. J Am Acad Dermatol 26:931-5
40. Stern RS, Lange R (1988) Cardiovascular disease, cancer, and cause of death in patients with psoriasis: 10 years prospective experience in a cohort of 1,380 patients. J Invest Dermatol 91:197-201
41. Stern RS, Laird N, Melski J et al (1984a) Cutaneous squamous-cell carcinoma in patients treated with PUVA. N Engl J Med 310:1156-61 (Pubitemid 14135391)
42. Stern RS, Nichols VT, Väkevä LH (1997) Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA) follow-up study. N Engl J Med 336:1041-5 (Pubitemid 27163855)
43. Stern RS, Rosa F, Baum C (1984b) Isotretinoin in pregnancy. J Am Acad Dermatol 10:851-4
44. Stern RS, Thibodeau LA, Parrish JA et al. (1979) Skin cancer after PUVA treatment for psoriasis. N Engl J Med 301:555
45. Vandenbroucke JP (2004) When are observational studies as credible as randomised trials? Lancet 363:1728-31 (Pubitemid 38670333)
46. Victora CG (1993) What's the denominator? Lancet 342:97-9
47. von Elm E, Altman DG, Egger M et al., STROBE Initiative (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet 370:1453-7
48. Whiteman DC, Watt P, Purdie DM et al. (2003) Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst 95:806-12 (Pubitemid 36798427)